PRF TECHNOLOGIES LTD (PRFX) Stock Price, Forecast & Analysis

NASDAQ:PRFX • IL0011651580

3.34 USD
+0.14 (+4.37%)
At close: Feb 19, 2026
3.13 USD
-0.21 (-6.29%)
After Hours: 2/19/2026, 8:26:16 PM

PRFX Key Statistics, Chart & Performance

Key Statistics
Market Cap2.61M
Revenue(TTM)N/A
Net Income(TTM)-14.59M
Shares780.00K
Float740.00K
52 Week High17.95
52 Week Low2.57
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-160.82
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2020-09-01
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
PRFX short term performance overview.The bars show the price performance of PRFX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60

PRFX long term performance overview.The bars show the price performance of PRFX in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of PRFX is 3.34 USD. In the past month the price decreased by -29.35%. In the past year, price decreased by -78.86%.

PRF TECHNOLOGIES LTD / PRFX Daily stock chart

PRFX Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
PRFX Full Technical Analysis Report

PRFX Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to PRFX. The financial health of PRFX is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
PRFX Full Fundamental Analysis Report

PRFX Financial Highlights

Over the last trailing twelve months PRFX reported a non-GAAP Earnings per Share(EPS) of -160.82. The EPS increased by 81.22% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -130.69%
ROE -172.78%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%96.15%
Sales Q2Q%N/A
EPS 1Y (TTM)81.22%
Revenue 1Y (TTM)N/A
PRFX financials

PRFX Forecast & Estimates


Analysts
Analysts43.33
Price TargetN/A
EPS Next Y38.91%
Revenue Next YearN/A
PRFX Analyst EstimatesPRFX Analyst Ratings

PRFX Ownership

Ownership
Inst Owners0.42%
Ins OwnersN/A
Short Float %N/A
Short Ratio0.09
PRFX Ownership

PRFX Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
LLY ELI LILLY & CO30.49964.817B
JNJ JOHNSON & JOHNSON21.19590.254B
MRK MERCK & CO. INC.22.52301.963B
PFE PFIZER INC8.94155.618B
BMY BRISTOL-MYERS SQUIBB CO9.91121.595B
ZTS ZOETIS INC18.5356.906B
RPRX ROYALTY PHARMA PLC- CL A8.726.172B
VTRS VIATRIS INC6.3218.486B
ELAN ELANCO ANIMAL HEALTH INC24.112.312B
AXSM AXSOME THERAPEUTICS INC227.339.313B

About PRFX

Company Profile

PRFX logo image PRF Technologies Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. The firm is a producer of speciality pharmaceuticals as well as energy analytics powered by artificial intelligence (AI). The Firm develops reformulated and sustained‑release drug‑delivery platforms that combine proven generic medicines with proprietary extended‑release systems to improve patient outcomes. One of the Company's products is PRF‑110 - a ropivacaine‑based formulation designed to deliver localised, extended postoperative analgesia. The firm also advances OcuRingTD, a bio‑erodible drug‑release ring integrated with intraocular lenses for continuous delivery of medications in cataract surgery.In the energy analytics sector the Company operates DeepSolar platform that provides AI‑powered monitoring, forecasting, and optimisation tools for solar asset performance.

Company Info

PRF TECHNOLOGIES LTD

65 Yigal Alon St.

TEL AVIV-YAFO 6745442 IL

CEO: Ilan Hadar

Employees: 2

PRFX Company Website

PRFX Investor Relations

Phone: 97237177051

PRF TECHNOLOGIES LTD / PRFX FAQ

What does PRF TECHNOLOGIES LTD do?

PRF Technologies Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. The firm is a producer of speciality pharmaceuticals as well as energy analytics powered by artificial intelligence (AI). The Firm develops reformulated and sustained‑release drug‑delivery platforms that combine proven generic medicines with proprietary extended‑release systems to improve patient outcomes. One of the Company's products is PRF‑110 - a ropivacaine‑based formulation designed to deliver localised, extended postoperative analgesia. The firm also advances OcuRingTD, a bio‑erodible drug‑release ring integrated with intraocular lenses for continuous delivery of medications in cataract surgery.In the energy analytics sector the Company operates DeepSolar platform that provides AI‑powered monitoring, forecasting, and optimisation tools for solar asset performance.


What is the stock price of PRF TECHNOLOGIES LTD today?

The current stock price of PRFX is 3.34 USD. The price increased by 4.37% in the last trading session.


What is the dividend status of PRF TECHNOLOGIES LTD?

PRFX does not pay a dividend.


What is the ChartMill rating of PRF TECHNOLOGIES LTD stock?

PRFX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Would investing in PRF TECHNOLOGIES LTD be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PRFX.